logo
  

Continental AG FY23 Profit Surges, Lifts Dividend; Sees Growth In FY24

German automotive parts maker Continental AG (CTTAY.PK) on Thursday reported that its fiscal 2023 net income attributable to the shareholders surged to 1.16 billion euros from last year's 66.6 million euros.

Earnings per share were 5.78 euros, up from prior year's 0.33 euro.

Adjusted operating result or adjusted EBIT climbed 31.6 percent from last year to 2.52 billion euros, corresponding to an adjusted EBIT margin of 6.1 percent, up from 4.9 percent last year. All three group sectors contributed to the improved adjusted EBIT margin.

Continental achieved consolidated sales of 41.42 billion euros, a growth of 5.1 percent from last year's 39.41 billion euros. Adjusted sales increased 5 percent to 41.30 billion euros.

Further, the Continental Executive Board will propose a 0.70 euro increase in the dividend to 2.20 euros per share for the past fiscal year.

Looking ahead for fiscal 2024, Continental anticipates consolidated sales of around 41.0 billion euros to 44.0 billion euros and an adjusted EBIT margin of around 6.0 to 7.0 percent.

Automotive group sector is expected to to generate sales of around 20.0 billion euros to 22.0 billion euros and an adjusted EBIT margin of around 3.0 to 4.0 percent.

For the current fiscal year, the technology company is targeting an increase in sales and earnings and the margin to improve further, particularly in the Automotive group sector, thanks mainly to the cost-cutting measures, price adjustments and efficiency improvements adopted last year. The goal is also to achieve above-market growth.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
AbbVie (ABBV) Monday announced a collaboration and option-to-license agreement with Gilgamesh Pharmaceuticals, a clinical stage neuroscience biotech firm, to develop next-generation treatment approaches and unmet needs in psychiatric disorders. AbbVie noted that the first-generation compounds may... Healthwest Minerals, Inc. d/b/a Mt. Capra Products has recalled 1,506 boxes of Goat Milk Formula Recipe Kit, also urging consumers to immediately discontinue use of the product as infant formula. The firm does not recommend using this product for infants from 0-12 months of age. Major companies, including Amazon.com Inc., Microsoft Corp., Morgan Stanley, Pfizer and others, have announced around 15 billion euros or $16.2 billion worth foreign investments in France as part of the country's annual 'Choose France' business summit, reports said. French President Emmanuel Macron kicks off the summit of 180 CEOs and executives on Monday, aiming to showcase foreign investment.

This week, we bring a mix of medical breakthroughs and setbacks. Lyko's MDMA therapy could become the first FDA-approved psychedelic treatment if all goes well as planned. A tragic loss occurred in Pfizer's Duchenne trial and a new study has raised concerns about ultra-processed foods. Find out why Long Beach declared a public health emergency and how Novavax's actions signal optimism.

View More Videos
Follow RTT